GCKR links the Bcr-Abl oncogene and Ras to the stress-activated protein kinase pathway

被引:27
作者
Shi, CS
Tuscano, JM
Witte, ON
Kehrl, JH
机构
[1] NIAID, Immunoregulat Lab, NIH, B Cell Mol Immunol Sect, Bethesda, MD 20892 USA
[2] Univ Calif Davis, Ctr Canc, Dept Oncol, Sacramento, CA 95817 USA
[3] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA USA
关键词
D O I
10.1182/blood.V93.4.1338.404k27_1338_1345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Bcr-Abl oncogene, found in Philadelphia chromosome-positive myelogenous leukemia (CML), activates Ras and triggers the stress-activated protein kinase (SAPK or Jun NH2-terminal kinase [JNK]) pathway. Interruption of Res or SAPK activation dramatically reduces Bcr-Abl-mediated transformation. Here, we report that Bcr-Abl through a Ras-dependent pathway signals the serine/threonine protein kinase GCKR (Germinal Center Kinase Related) leading to SAPK activation. Either an oncogenic form of Ras or Bcr-Abl enhances GCKR catalytic activity and its activation of SAPK, whereas inhibition of GCKR impairs Bcr-Abl-induced SAPK activation. Bcr-Abl mutants that are Impaired for GCKR activation ape also unable to activate SAPK, Consistent with GCKR being a functional target in CML, GCKR is constitutively active in CML cell lines and found in association with Bcr-Abl. Our results indicate that GCKR is a downstream target of Bcr-Abl and strongly implicate GCKR as a mediator of Bcr-Abl in its transformation of cells.
引用
收藏
页码:1338 / 1345
页数:8
相关论文
共 33 条
  • [1] DIFFERENTIAL COMPLEMENTATION OF BCR-ABL POINT MUTANTS WITH C-MYC
    AFAR, DEH
    GOGA, A
    MCLAUGHLIN, J
    WITTE, ON
    SAWYERS, CL
    [J]. SCIENCE, 1994, 264 (5157) : 424 - 426
  • [2] Peptides containing a consensus Ras binding sequence from Raf-1 and the GTPase activating protein NF1 inhibit Ras function
    Clark, GJ
    Drugan, JK
    Terrell, RS
    Bradham, C
    Der, CJ
    Bell, RM
    Campbell, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1577 - 1581
  • [3] p120 GAP modulates Ras activation of Jun kinases and transformation
    Clark, GJ
    Westwick, JK
    Der, CJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1677 - 1681
  • [4] THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY
    COSO, OA
    CHIARIELLO, M
    YU, JC
    TERAMOTO, H
    CRESPO, P
    XU, NG
    MIKI, T
    GUTKIND, JS
    [J]. CELL, 1995, 81 (07) : 1137 - 1146
  • [5] INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME
    DALEY, GQ
    VANETTEN, RA
    BALTIMORE, D
    [J]. SCIENCE, 1990, 247 (4944) : 824 - 830
  • [6] A cytoplasmic inhibitor of the JNK signal transduction pathway
    Dickens, M
    Rogers, JS
    Cavanagh, J
    Raitano, A
    Xia, ZG
    Halpern, JR
    Greenberg, ME
    Sawyers, CL
    Davis, RJ
    [J]. SCIENCE, 1997, 277 (5326) : 693 - 696
  • [7] Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase
    Diener, K
    Wang, XHS
    Chen, C
    Meyer, CF
    Keesler, G
    Zukowski, M
    Tan, TH
    Yao, ZB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) : 9687 - 9692
  • [8] BCR-ABL, THE HALLMARK OF CHRONIC MYELOID-LEUKEMIA IN MAN, INDUCES MULTIPLE HEMATOPOIETIC NEOPLASMS IN MICE
    ELEFANTY, AG
    HARIHARAN, IK
    CORY, S
    [J]. EMBO JOURNAL, 1990, 9 (04) : 1069 - 1078
  • [9] EZOE K, 1994, ONCOGENE, V9, P935
  • [10] ALTERNATIVE SIGNALS TO RAS FOR HEMATOPOIETIC TRANSFORMATION BY THE BCR-ABL ONCOGENE
    GOGA, A
    MCLAUGHLIN, J
    AFAR, DEH
    SAFFRAN, DC
    WITTE, ON
    [J]. CELL, 1995, 82 (06) : 981 - 988